Published in

Elsevier, Clinical Lymphoma, Myeloma and Leukemia, 2(18), p. 91-97, 2018

DOI: 10.1016/j.clml.2017.12.003

Links

Tools

Export citation

Search in Google Scholar

Should We Use Cell of Origin and Dual-protein Expression in Treating DLBCL?

Journal article published in 2018 by Peter A. Riedell ORCID, Sonali M. Smith ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO